See today's BioWorld Science
To read the full story, subscribe or sign in.
Neurology/psychiatric

Solid Biosciences gains IND clearance for Friedreich’s ataxia gene therapy

Jan. 8, 2025
Solid Biosciences Inc. has gained IND clearance from the FDA for SGT-212 for the treatment of Friedreich’s ataxia (FA).
BioWorld Science Regulatory Neurology/psychiatric Gene therapy FDA IND